TCA
CRL icon

Trifecta Capital Advisors’s Charles River Laboratories CRL Stock Holding History

Trifecta Capital Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$452 – 483
2025
Q1 		$452 Hold
3
– – ﹤0.01% 409
2024
Q4 		$554 Hold
3
– – ﹤0.01% 398
2024
Q3 		$591 Hold
3
– – ﹤0.01% 400
2024
Q2 		$620 Hold
3
– – ﹤0.01% 404
2024
Q1 		$813 Hold
3
– – ﹤0.01% 387
2023
Q4 		$710 Hold
3
– – ﹤0.01% 421
2023
Q3 		$588 Hold
3
– – ﹤0.01% 412
2023
Q2 		$631 Hold
3
– – ﹤0.01% 406
2023
Q1 		$606 Hold
3
– – ﹤0.01% 410
2022
Q4 		$654 Buy
+3
New +$655 ﹤0.01% 409

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $12B AUM 34.44% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $74.9B AUM 11.27% 1-Year Est. Return